» Articles » PMID: 29666772

Frizzled-related Proteins 4 (SFRP4) Rs1802073G Allele Predicts the Elevated Serum Lipid Levels During Acitretin Treatment in Psoriatic Patients from Hunan, China

Overview
Journal PeerJ
Date 2018 Apr 19
PMID 29666772
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Acitretin is a second-generation synthetic retinoid, and is widely used for treating the severe psoriasis vulgaris. However, it should be chosen with caution for its cardiovascular risk, and it is reported that acitretin may increase the serum lipids. The purpose of this study is to investigate the relationship between the Frizzled-related proteins 4 (SFRP4) rs1802073 polymorphism and the changes of serum lipids in Chinese psoriatic patients during the treatment with acitretin.

Methods: In our study, 100 psoriatic patients were recruited systematically treated with acitretin (30 mg/day) for at least eight weeks. Data of the patients' demographic and clinical characteristics and the results of serum triglyceride (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C) were collected pre- and post-treatment.

Results: A total of 84 psoriatic patients were enrolled and divided into three groups by SFRP4 rs1802073 genotypes. The patients who carried with TT genotype had maintained levels of TG and LDL-C after acitretin treatment, while patients with GG/GT genotypes had significantly elevated levels of serum TG and LDL-C compared to the TT genotype (ΔTG%: 27.53 ± 59.13 vs -1.47 ± 37.79,  = 0.026, ΔLDL-C%: 10.62 ± 26.57 vs -1.29 ± 17.07,  = 0.042). The association of rs1802073 with TG and LDL-C profiles remained significant after adjusting for age, gender, and body mass index. Although without significance, the pre-post change in serum level of TC across rs1802073 GG/GT genotypes demonstrated a trend similar to TG and LDL, and the serum level of HDL-C demonstrated a trend opposite to TG, TC and LDL.

Conclusions: Our results demonstrated that SFRP4 rs1802073 polymorphism was found to be associated with elevated serum lipid levels after acitretin treatment, and it may serve as a genetic marker of safe and precise treatment for individual psoriatic patients.

Citing Articles

17 variants interaction of Wnt/β-catenin pathway associated with development of osteonecrosis of femoral head in Chinese Han population.

Shi C, Li X, Sun Y, Du Z, Zhang G, Che Z Sci Rep. 2024; 14(1):7301.

PMID: 38538713 PMC: 10973331. DOI: 10.1038/s41598-024-57929-8.


Federated Machine Learning for Skin Lesion Diagnosis: An Asynchronous and Weighted Approach.

Mateen Yaqoob M, Alsulami M, Amir Khan M, Alsadie D, Jilani Saudagar A, Alkhathami M Diagnostics (Basel). 2023; 13(11).

PMID: 37296816 PMC: 10252842. DOI: 10.3390/diagnostics13111964.


Pharmaco-Omics in Psoriasis: Paving the Way towards Personalized Medicine.

Antonatos C, Asmenoudi P, Panoutsopoulou M, Vasilopoulos Y Int J Mol Sci. 2023; 24(8).

PMID: 37108251 PMC: 10139144. DOI: 10.3390/ijms24087090.


Towards Personalized Medicine in Psoriasis: Current Progress.

Camela E, Potestio L, Ruggiero A, Ocampo-Garza S, Fabbrocini G, Megna M Psoriasis (Auckl). 2022; 12:231-250.

PMID: 36071793 PMC: 9444142. DOI: 10.2147/PTT.S328460.


Polymorphisms of SLCO1B1 rs4149056 and SLC22A1 rs2282143 are associated with responsiveness to acitretin in psoriasis patients.

Chen W, Zhang X, Zhang W, Peng C, Zhu W, Chen X Sci Rep. 2018; 8(1):13182.

PMID: 30181619 PMC: 6123456. DOI: 10.1038/s41598-018-31352-2.

References
1.
Orfanos C, Zouboulis C, Geilen C . Current use and future potential role of retinoids in dermatology. Drugs. 1997; 53(3):358-88. DOI: 10.2165/00003495-199753030-00003. View

2.
Grayson M . Psoriasis. Nature. 2012; 492(7429):S49. DOI: 10.1038/492S49a. View

3.
Mi K, Johnson G . Role of the intracellular domains of LRP5 and LRP6 in activating the Wnt canonical pathway. J Cell Biochem. 2005; 95(2):328-38. DOI: 10.1002/jcb.20400. View

4.
Carmon K, Loose D . Secreted frizzled-related protein 4 regulates two Wnt7a signaling pathways and inhibits proliferation in endometrial cancer cells. Mol Cancer Res. 2008; 6(6):1017-28. DOI: 10.1158/1541-7786.MCR-08-0039. View

5.
Nozaki Y, Kumagai K, Miyata N, Niwa M . Pravastatin reduces steroid-induced osteonecrosis of the femoral head in SHRSP rats. Acta Orthop. 2012; 83(1):87-92. PMC: 3278663. DOI: 10.3109/17453674.2011.641103. View